Test Price
2,800 AED✅ Home Collection Available
DLG3 Gene Mental Retardation, X‑Linked Type 90 Genetic Test in UAE | 2800 AED | DHA Guidelines
Executive Summary & Core Metrics
Executive Summary
ISO‑certified Next‑Generation Sequencing (NGS) test for the DLG3 gene with 99.9% diagnostic sensitivity, delivered under strict DHA and UAE data protection compliance. Home collection available across all emirates via temperature‑controlled cold‑chain logistics, VIP mobile phlebotomy, and direct insurance billing verification on WhatsApp.
Test price: 2,800 AED. Turnaround time: 3–4 weeks. Sample types: whole blood, DNA FTA card, or pre‑extracted DNA. Methodology: NGS with full bioinformatics analysis.
Test Overview & Methodology
The DLG3 gene (Discs Large MAGUK Scaffold Protein 3) is critical for synaptic function; pathogenic variants cause X‑linked intellectual disability type 90 (XLID90). This NGS‑based test sequences the entire coding region and intron‑exon boundaries to detect single nucleotide variants, small insertions/deletions, and copy number changes with >99.9% analytical sensitivity.
| Feature | Our Test – DLG3 NGS (ISO‑Accredited) | Closest Alternative – Single‑Gene Sanger Sequencing |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) with full bioinformatics | Sanger sequencing – only the DLG3 gene |
| Diagnostic Precision | 99.9% sensitivity for SNVs, indels, CNVs | ~99% for point mutations; may miss large deletions |
| Turnaround Time | 3‑4 weeks | 6‑8 weeks |
| Sample Requirements | Whole blood, DNA FTA card, or extracted DNA – three options | Whole blood only |
| Pre‑test Information | Clinical history + genetic counselling session with pedigree chart | Often no formal genetic counselling included |
Physician Insight & Safety Protocols
“Genetic testing for DLG3‑related intellectual disability must always be correlated with clinical phenotypes and family history. A negative result does not exclude other genetic aetiologies, and I strongly recommend comprehensive genetic counselling before sampling. If the patient is a minor, consent from a legal guardian is mandatory under UAE personal data protection law.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration No. 9294403.
Advisory Notice
Do not discontinue prescribed medication without consulting your doctor. This test is for diagnostic purposes only and should not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Home phlebotomy is withheld if active severe bleeding disorder, unstable haemodynamic status, or acute infection is identified during pre‑screening.
- Exclusion also applies to patients unable to provide informed consent (or whose legal guardian cannot attend).
- If severe pain, syncope, or prolonged bleeding occurs after sample collection, seek immediate medical attention.
- Individuals with known allergy to antiseptics or latex must inform the phlebotomist in advance.
Patient FAQ & Clinical Guidance
1. What does the DLG3 NGS test detect and why is it important?
The DLG3 NGS test detects pathogenic variants in the DLG3 gene that cause X‑linked intellectual disability type 90, enabling precise diagnosis, prognosis, and family risk assessment. Early identification guides developmental interventions and informs recurrence risk for future pregnancies.
2. How is the sample collected and what are the payment options?
A certified phlebotomist collects whole blood, a DNA FTA card, or accepts pre‑extracted DNA via our cold‑chain home service; insurance coverage is verified instantly on WhatsApp before collection. Direct billing to your insurer is available after eligibility check.
3. Will I receive genetic counselling and result interpretation?
Yes, a mandatory pre‑test genetic counselling session with pedigree charting is included, and a post‑test telephonic consultation with a DHA‑licensed genetic specialist explains the findings clinically. All genetic data is protected under UAE Personal Data Protection Law.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
This test is performed under DHA Facility License No. 1143 and adheres to the following UAE legal frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensures confidentiality of genetic and clinical data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governs secure digital health data exchange.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – defines standards for clinical safety and patient consent.
- ISO 9001:2015 quality management certification (Certificate No. INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | DLG3 Gene Mental Retardation, X‑Linked Type 90 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood, DNA FTA card, or extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) with full bioinformatics |
| ICD-10-CM Code | F78.1 (X‑linked intellectual disability) |
| LOINC Code | 81261-4 (DLG3 gene sequencing) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians